Functional characterization of corticotropin-releasing factor type 1 receptor endogenously expressed in human embryonic kidney 293 cells

European Journal of Pharmacology

Volumn 390, Issue 1-2, 2000, Pages 51-59

  Dautzenberg, Frank M ^a   Higelin, Jacqueline ^a   Teichert, Ulrich ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

cAMP; Ligand binding; mRNA detection; Receptor expression

Indexed keywords

ASTRESSIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR AGONIST; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR DERIVATIVE; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CYCLIC AMP; MESSENGER RNA; RECEPTOR SUBTYPE; SAUVAGINE; UNCLASSIFIED DRUG; UROCORTIN;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; EMBRYO; EXPRESSION VECTOR; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CELL; LIGAND BINDING; MONKEY; NERVE CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, NORTHERN; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; HUMANS; KIDNEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION;

EID: 0034711989     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00915-2     Document Type: Article

References (49)

1. Anderson L., Alexander C.L., Faccenda E., Eidne K.A. Rapid desensitization of the thyrotropin-releasing hormone receptor expressed in single human embryonal kidney 293 cells. Biochem. J. 311:1995;385-392.
2. Andrews P.W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol. 103:1984;285-293.
3. Antoni F.C., Barnard R.J.O., Shipston M.J., Smith S.M., Simpson J., Paterson J.M. Calcineurin feedback inhibition of agonist-evoked cAMP formation. J. Biol. Chem. 270:1995;28055-28061.
4. Arborelius L., Owens M.J., Plotsky P.M., Nemeroff C.B. The role of corticotropin-releasing factor in depression and anxiety disorders. J. Endocrinol. 160:1999;1-12.
5. 2 α and β splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay. Neuropharmacology. 38:1999;441-448.
6. Bot G., Blake A.D., Li S., Reisine T. Mutagenesis of a single amino acid in the rat μ-opioid receptor discriminates ligand binding. J. Neurochem. 70:1998;358-365.
7. 1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350.
8. Chalmers D.T., Lovenberg T.W., Grigoriadis D.E., Behan D.P., De Souza E.B. Corticotropin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 17:1996;166-172.
9. 2-adrenergic receptor to different G proteins by protein kinase A. Nature. 390:1998;88-91.
10. Dautzenberg F.M., Dietrich K., Palchaudhuri M.R., Speiss J. Identification of two corticotropin-releasing factor receptors with high ligand selectivity from Xenopus laevis: unusual pharmacology of the type 1 receptor. J. Neurochem. 69:1997;1640-1649.
11. Dautzenberg F.M., Kilpatrick G.J., Wille S., Hauger R.L. The ligand selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand selective profile. J. Neurochem. 73:1999;821-829.
12. Dautzenberg F.M., Wille S., Lohmann R., Speiss J. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site. Proc. Natl. Acad. Sci. U.S.A. 95:1998;4941-4945.
13. Dieterich K.D., De Souza E.B. Functional corticotropin-releasing factor receptors in human neuroblastoma cells. Brain Res. 733:1996;113-118.
14. Dieterich K.D., Grigoriadis D.E., De Souza E.B. Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and Northern blot analysis data. Endocrinology. 135:1994;1551-1558.
15. Donaldson C., Sutton S., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J., Vaughan J.M., Vale W.W. Cloning and characterization of human urocortin. Endocrinology. 137:1996;2167-2170.
16. Dunn A.J., Berridge C.W. Physiological and behavioral responses of corticotropin releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res. Rev. 15:1990;71-100.
17. Graham F.L., Smiley J., Russell W.C., Nairn R. Characteristics of a human cell line transformed by DNA for human adenovirus type 5. J. Gen. Virol. 36:1977;59-74.
18. Hauger R.L., Dautzenberg F.M. Regulation of the stress response by corticotropin-releasing factor receptors. Conn P.M., Freedman M.E. Neuroendocrinology in Physiology and Medicine. 1999;261-286 Humana Press, Totowa, New Jersey.
19. Hauger R.L., Dautzenberg F.M., Flaccus A., Liepold T., Speiss J. Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery. J. Neurochem. 68:1997;2308-2316.
20. Hiltscher R., Seuwen K., Boddeke H.W., Sommer B., Laurie D.J. Functional coupling of human metabotropic glutamate receptor hmGlu1d: comparison to splice variants hmGlu1a and -1b. Neuropharmacology. 37:1998;827-837.
21. Hogg J.E., Myers J., Hutson P.H. The human neuroblastoma cell line, IMR-32, expresses functional corticotropin-releasing factor receptors. Eur. J. Pharmacol. 312:1996;257-261.
22. + channels. Proc. Natl. Acad. Sci. U.S.A. 95:1998;14991-14996.
23. Kiang J.G., Ding X.Z., Gist I.D., Jones R.R., Tsokos G.C. Corticotropin-releasing factor induces phosphorylation of phospholipase C-γ at tyrosine residues via its receptor 2β in human epidermoid A-431 cells. Eur. J. Pharmacol. 363:1998;203-210.
24. Koch T., Schulz S., Schröder H., Wolf R., Raulf E., Höllt V. Carboxyl-terminal splicing of the rat μ opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273:1998;13652-13657.
25. 2γ receptor. Mol. Endocrinol. 12:1998;1077-1085.
26. Kyritsis A.P., Tsokos M., Triche T.J., Chader G.J. Retinoblastoma-origin from a primitive neuroectodermal cell? Nature. 307:1984;471-473.
27. oα selectively associate with the cloned somatostatin receptor subtype SSTR2. J. Biol. Chem. 268:1993;10721-10727.
28. Lederis K., Letter A., McMaster D., Moore G. Complete amino acid sequence of urotensin-I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus. Science. 218:1982;162-164.
29. Liaw C.W., Lovenberg T.W., Barry G., Oltersdorf T., Grigoriadis D.E., De Souza E.B. Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid. Endocrinology. 137:1996;72-77.
30. Lin K., Sadee W., Quillan J.M. Rapid measurements of intracellular calcium using a fluorescence plate reader. Biotechniques. 26:1999;318-322.
31. McHale M., Coldwell M.C., Herrity N., Boyfield I., Winn F.M., Ball S., Cook T., Robinson J.H., Gloger I.S. Expression and functional characterization of a synthetic version of the human D4 dopamine receptor in a stable human cell line. FEBS Lett. 345:1994;147-150.
32. Mellon P., Parker V., Gluzman Y., Maniatis T. Identification of DNA sequences required for transcription of the human alpha 1-globin gene in a new SV40 host-vector system. Cell. 27:1981;279-288.
33. Mestek A., Hurley J.H., Bye L.S., Campbell A.D., Chen Y., Tian M., Liu J., Schulman H., Yu L. The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15:1995;2396-2406.
34. Mollereau C., Parmentier M., Mailleux P., Butour J.L., Moisand C., Chalon P., Caput D., Vassart G., Meunier J.C. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 341:1994;33-38.
35. Montecucchi P.C., Henschen A. Amino acid composition and sequence analysis of sauvagine, a new active peptide from the skin of Phyllomedusa sauvagei. Int. J. Pept. Protein Res. 18:1981;113-120.
36. Munson P.J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:1980;220-239.
37. Palchaudhuri M.R., Hauger R.L., Wille S., Fuchs E., Dautzenberg F.M. Isolation and pharmacological characterization of two functional splice variants of corticotropin-releasing factor type 2 receptor from Tupaia belangeri. J. Neuroendocrinol. 11:1999;419-428.
38. Palchaudhuri M.R., Wille S., Mevenkamp G., Speiss J., Fuchs E., Dautzenberg F.M. Corticotropin-releasing factor receptor type 1 from Tupaia belangeri: cloning, functional expression and tissue distribution. Eur. J. Biochem. 258:1998;78-84.
39. Pozzoli G., Bilezikkijan L.M., Perrin M.H., Blount A.L., Vale W.W. Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of the type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. Endocrinology. 137:1996;65-71.
40. Reisine T., Hoffmann A. Desensitization of corticotropin-releasing factor receptors. Biochem. Biophys. Res. Commun. 111:1983;919-925.
41. Sanchez M.M., Young L.Y., Plotsky P.M., Insel T.R. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J. Comp. Neurol. 408:1999;365-377.
42. Schachter J.B., Sromek S.M., Nicholas R.A., Harden T.K. HEK293 human embryonic kidney cells endogenously express the P2Y1 and P2Y2 receptors. Neuropharmacology. 36:1997;1181-1187.
43. Thomas D.R., Gittins S.A., Collin L.L., Middlemiss D.N., Riley G., Hagan J., Gloger I., Ellis C.E., Forbes I.T., Brown A.M. Functional characterization of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719. Br. J. Pharmacol. 124:1998;1300-1306.
44. Turnbull A.V., Rivier C. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc. Soc. Exp. Biol. Med. 215:1997;1-10.
45. Valdenaire O., Giller T., Breu V., Gottowik J., Kilpatrick G. A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor. Biochim. Biophys. Acta. 1352:1997;129-132.
46. Valiquette M., Vu H.K., Yue S.Y., Wahlstedt C., Walker P. Involvement of Trp-284, Val-296, and Val-297 of the human δ-opioid receptor in binding of δ-selective ligands. J. Biol. Chem. 271:1996;18789-18796.
47. i protein-coupled plasma membrane receptor by sphingosine-1-phosphate. J. Biol. Chem. 271:1996;2082-2087.
48. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.
49. Wille S., Sydow S., Palchaudhuri M.R., Speiss J., Dautzenberg F.M. Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high affinity ligand binding. J. Neurochem. 72:1999;388-395.